Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.14 is in line with its 5-year average of 2.37, near the low end of its 5-year range (0.05–7.87).
As of the fiscal period ended Tuesday, June 30, 2026. 149.75% above its 12-month average of 0.86.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.14.
QUICK RATIO (ACID-TEST)
2.14
QUICK RATIO (ACID-TEST) AVG TTM
0.86
QUICK RATIO (ACID-TEST) AVG 3Y
0.37
QUICK RATIO (ACID-TEST) AVG 5Y
2.37
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+149.75%
CURRENT VS 3Y AVG
+484.58%
CURRENT VS 5Y AVG
-9.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-36.14%
vs the sector median at left
Onconetix, Inc.
Market Cap
$2.37M
Quick Ratio (Acid-Test)
2.14
TTM Avg
0.86
3Y Avg
0.37
5Y Avg
2.37
Market Cap
$2.37M
Quick Ratio (Acid-Test)
2.64
TTM Avg
2.37
3Y Avg
1.52
5Y Avg
1.27
Market Cap
$2.38M
Quick Ratio (Acid-Test)
0.11
TTM Avg
0.75
3Y Avg
3.92
5Y Avg
2.68
Market Cap
$2.38M
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.19
3Y Avg
3.93
5Y Avg
6.93
Market Cap
$2.32M
Quick Ratio (Acid-Test)
12.73
TTM Avg
22.34
3Y Avg
19.49
5Y Avg
14.70
Market Cap
$2.44M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.70
3Y Avg
0.81
5Y Avg
0.98
Market Cap
$2.54M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.72
3Y Avg
3.92
5Y Avg
2.64
Market Cap
$2.14M
Quick Ratio (Acid-Test)
0.21
TTM Avg
0.87
3Y Avg
0.72
5Y Avg
1.52
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Onconetix, Inc. (ONCO) | $2.37M | 2.14 | 0.86 | 0.37 | 2.37 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | 2.64 | 2.37 | 1.52 | 1.27 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | 0.11 | 0.75 | 3.92 | 2.68 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | 0.94 | 1.19 | 3.93 | 6.93 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 12.73 | 22.34 | 19.49 | 14.70 |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | 0.40 | 0.70 | 0.81 | 0.98 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | 1.41 | 1.72 | 3.92 | 2.64 |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | 1.54 | 1.94 | 2.53 | 3.69 |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | 0.21 | 0.87 | 0.72 | 1.52 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | 1.54 | 2.65 | 3.41 | 4.73 |
Quick Ratio
2.14
Excludes inventory
Current Ratio
2.21
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.14 |
| 2026-03-31 | 1.37 |
| 2025-12-31 | 0.65 |
| 2025-09-30 | 0.07 |
| 2025-06-30 | 0.06 |
| 2025-03-31 | 0.16 |
| 2024-12-31 | 0.05 |
| 2024-09-30 | 0.05 |
| 2024-06-30 | 0.09 |
| 2024-03-31 | 0.28 |
| 2023-12-31 | 0.32 |
| 2023-09-30 | 0.46 |
| 2023-06-30 | 0.84 |
| 2023-03-31 | 7.87 |
| 2022-12-31 | 6.69 |
| 2022-09-30 | 6.74 |
| 2022-06-30 | 7.61 |
| 2022-03-31 | 6.73 |
| 2021-12-31 | 1.41 |
| 2021-09-30 | 3.86 |
| 2021-03-31 | 0.00 |
